| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 85,556 | 82,233 | ||
| Marketable investment securities | 201,986 | 193,697 | ||
| Accounts receivable, net | 49,482 | 52,311 | ||
| Inventory | 8,650 | 8,366 | ||
| Prepaid expenses and other current assets | 11,895 | 12,061 | ||
| Total current assets | 357,569 | 348,668 | ||
| Long-term accounts receivable, net | 2,050 | 1,132 | ||
| Property and equipment, net | 84,885 | 74,060 | ||
| Operating lease assets | 15,151 | 15,503 | ||
| Goodwill and other intangible assets, net | 101,849 | 104,125 | ||
| Other assets long-term | 1,282 | 1,241 | ||
| Total assets | 562,786 | 544,729 | ||
| Accounts payable | 12,211 | 13,181 | ||
| Accrued compensation | 31,763 | 24,973 | ||
| Contingent consideration | 1,000 | 1,000 | ||
| Operating lease liabilities | 1,449 | 1,571 | ||
| Current portion of long-term debt | 0 | 1,944 | ||
| Other accrued and current liabilities | 8,885 | 8,221 | ||
| Total current liabilities | 55,308 | 50,890 | ||
| Long-term debt | 10,049 | 8,096 | ||
| Noncurrent portion of contingent consideration | 1,500 | 1,500 | ||
| Noncurrent operating lease liabilities | 25,302 | 25,377 | ||
| Noncurrent finance lease liabilities | 339 | 364 | ||
| Deferred tax liability | 3,242 | 3,126 | ||
| Total liabilities | 95,740 | 89,353 | ||
| Common stock, 0.001 par value per share 200,000,000 shares authorized as of september30, 2025 and december31, 2024 29,161,863 and 28,483,195 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 29 | 29 | ||
| Additional paid-in capital | 688,729 | 676,759 | ||
| Retained Earnings Accumulated Deficit | - | -221,500 | ||
| Accumulated deficit | -221,952 | -221,451 | ||
| Accumulated other comprehensive income | 240 | 39 | ||
| Total stockholders equity | 467,046 | 455,376 | ||
| Total liabilities and stockholders equity | 562,786 | 544,729 | ||
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)